Correlation Between Vigil Neuroscience and Connect Biopharma
Can any of the company-specific risk be diversified away by investing in both Vigil Neuroscience and Connect Biopharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Vigil Neuroscience and Connect Biopharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Vigil Neuroscience and Connect Biopharma Holdings, you can compare the effects of market volatilities on Vigil Neuroscience and Connect Biopharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Vigil Neuroscience with a short position of Connect Biopharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Vigil Neuroscience and Connect Biopharma.
Diversification Opportunities for Vigil Neuroscience and Connect Biopharma
0.02 | Correlation Coefficient |
Significant diversification
The 3 months correlation between Vigil and Connect is 0.02. Overlapping area represents the amount of risk that can be diversified away by holding Vigil Neuroscience and Connect Biopharma Holdings in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Connect Biopharma and Vigil Neuroscience is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Vigil Neuroscience are associated (or correlated) with Connect Biopharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Connect Biopharma has no effect on the direction of Vigil Neuroscience i.e., Vigil Neuroscience and Connect Biopharma go up and down completely randomly.
Pair Corralation between Vigil Neuroscience and Connect Biopharma
Given the investment horizon of 90 days Vigil Neuroscience is expected to under-perform the Connect Biopharma. But the stock apears to be less risky and, when comparing its historical volatility, Vigil Neuroscience is 1.22 times less risky than Connect Biopharma. The stock trades about -0.23 of its potential returns per unit of risk. The Connect Biopharma Holdings is currently generating about -0.17 of returns per unit of risk over similar time horizon. If you would invest 122.00 in Connect Biopharma Holdings on August 24, 2024 and sell it today you would lose (23.00) from holding Connect Biopharma Holdings or give up 18.85% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Insignificant |
Accuracy | 95.65% |
Values | Daily Returns |
Vigil Neuroscience vs. Connect Biopharma Holdings
Performance |
Timeline |
Vigil Neuroscience |
Connect Biopharma |
Vigil Neuroscience and Connect Biopharma Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Vigil Neuroscience and Connect Biopharma
The main advantage of trading using opposite Vigil Neuroscience and Connect Biopharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Vigil Neuroscience position performs unexpectedly, Connect Biopharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Connect Biopharma will offset losses from the drop in Connect Biopharma's long position.Vigil Neuroscience vs. Molecular Partners AG | Vigil Neuroscience vs. Pmv Pharmaceuticals | Vigil Neuroscience vs. Monte Rosa Therapeutics | Vigil Neuroscience vs. Entrada Therapeutics |
Connect Biopharma vs. Assembly Biosciences | Connect Biopharma vs. Instil Bio | Connect Biopharma vs. CytomX Therapeutics | Connect Biopharma vs. Achilles Therapeutics PLC |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bollinger Bands module to use Bollinger Bands indicator to analyze target price for a given investing horizon.
Other Complementary Tools
Bonds Directory Find actively traded corporate debentures issued by US companies | |
Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated |